$175 millionVerdict

Kline & Specter Wins $175 Million Roundup Cancer Verdict Against Monsanto

Verdict · Philadelphia County, PA · 2023

After trial: Affirmed in May 2025.

Won by Kline & Specter, PC.

A Philadelphia jury awarded Ernest Caranci $175 million after finding that decades of Roundup use caused his non-Hodgkin lymphoma and that Monsanto failed to warn of the risk. Kline & Specter tried the case, the first Roundup trial in Philadelphia, and the verdict was later upheld on appeal.

What happened

Ernest Caranci kept his Philadelphia lawn and garden in order for a quarter century. From 1989 to 2014 he sprayed Roundup two or three times a week, going through more than 500 gallons of the weed killer, and he did it without gloves, a mask, or any other protective gear. Monsanto, which made the product, never recommended such precautions on the label. Caranci was later diagnosed with non-Hodgkin lymphoma, a cancer of the lymphatic system. His claim centered on glyphosate, the active ingredient in Roundup, and whether long exposure to it had caused his disease.

Kline & Specter took the case to trial in Philadelphia Common Pleas Court, with Thomas R. Kline as co-lead counsel alongside Texas attorney Jason Itkin. It was the first Roundup trial held in Philadelphia, and it ran three weeks before a 12-person jury. The plaintiffs argued failure to warn. Monsanto knew, or should have known, that glyphosate carried a cancer risk, yet it sold Roundup for home use without a warning and without advising users to protect themselves. The defense maintained that glyphosate is safe and that regulators had repeatedly cleared it. Caranci, 83 at the time of the verdict, was undergoing treatment for the fourth recurrence of his cancer.

On October 27, 2023, the jury found for Caranci and awarded $175 million. The award broke down into $25 million in compensatory damages and $150 million in punitive damages, a measure of how the jury judged Monsanto's conduct. The company fought the result. It moved to overturn or cut the award, arguing in part that a court officer had improperly pushed the deadlocked jury toward a decision. The trial judge rejected those arguments, kept the $175 million in place, and added roughly $2.3 million in delay damages.

Caranci's case was one of several Roundup trials Kline & Specter carried to a jury in Philadelphia, and the firm won larger awards in later trials, including a $2.25 billion verdict in January 2024. His remained the city's first finding of liability against Monsanto over the weed killer. When the Pennsylvania Superior Court affirmed the judgment in May 2025, the award still stood at $175 million.

Sources

This account is drawn from contemporaneous public reporting and the court record.

More proven verdicts from Kline & Specter, PC

All Kline & Specter, PC proven verdicts →
$4.85 billionSettlementGroup recoveryProduct LiabilityLA

As chair of the plaintiffs' negotiating committee and Liaison Counsel in the Vioxx multidistrict litigation, Russ Herman directed the negotiations that produced a $4.85 billion settlement with Merck resolving approximately 45,000 to 50,000 personal-injury claims.

2007 · U.S. District Court, Eastern District of Louisiana (MDL-1657)Read the full story →
$400 millionVerdictOn appealProduct LiabilityPA

A Philadelphia jury found that Monsanto failed to warn that Roundup could cause cancer and awarded John McKivison $2.25 billion. The trial judge later reduced the award to $400 million.

2024 · Philadelphia County, PARead the full story →
$265 millionSettlementGroup recoveryWrongful DeathPA

After Amtrak Train 188 derailed in Philadelphia in May 2015, killing eight and injuring more than 200, Kline & Specter's Thomas R. Kline led the plaintiffs' negotiations that produced a $265 million settlement fund for the victims.

2016 · Philadelphia, PA (federal)Read the full story →
$207.6 millionVerdictMedical MalpracticePA

A Philadelphia jury found the Hospital of the University of Pennsylvania liable for the brain injury a newborn suffered when staff delayed a cesarean section, a $182.7 million verdict that grew to a molded judgment of about $207.6 million, the largest medical malpractice award in Pennsylvania history. Kline & Specter argued and won the appeal, where the Pennsylvania Superior Court affirmed the full $207.6 million judgment in July 2025.

2025 · Philadelphia County, PARead the full story →

Related product liability verdicts

$25 billionSettlementGroup recoveryNY

Sullivan Papain was among the firms representing New York State against Philip Morris, R.J. Reynolds, Brown & Williamson, and Lorillard, securing a $25 billion recovery through the 1998 Master Settlement Agreement.

Sullivan Papain Block McManus Coffinas & Cannavo1998 · New York State (Master Settlement Agreement)Read the full story →
$11.3 billionSettlementGroup recoveryFL

C. Steven Yerrid, the youngest of Florida's 11-lawyer 'Dream Team,' added racketeering and conspiracy charges that tripled the damages ceiling, helping the state secure what was then the largest civil settlement in American history against the tobacco industry.

The Yerrid Law Firm, Terrell Hogan and The Maher Law Firm1997 · Florida (State v. American Tobacco Co.)Read the full story →
$10.9 billionSettlementGroup recoveryCA

As co-lead counsel in the federal Roundup multidistrict litigation and the first firm to sue Monsanto in 2015, Weitz and Luxenberg helped negotiate a $10.9 billion settlement resolving approximately 125,000 non-Hodgkin lymphoma claims against Bayer-owned Monsanto.

Weitz & Luxenberg2020 · U.S. District Court, Northern District of California (MDL No. 2741)Read the full story →
$5.5 billionSettlementGroup recoveryNJ

After fifteen years of litigation and three failed bankruptcy maneuvers by Johnson and Johnson subsidiaries, Ashcraft and Gerel attorneys R. Bryant McCulley and Michelle Parfitt helped negotiate a global, uncapped settlement of at least $5.5 billion covering approximately 76,000 ovarian-cancer claims.

Ashcraft & Gerel, LLP2026 · D.N.J. MDL No. 2738Read the full story →